Pre-Antibiotic Treatment Followed by Prolonged Repeated Faecal Microbiota Transplantation Improves Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome: An Observational Australian Clinical Experience
Table 3
Descriptive summary of abdominal symptom scores across baseline, week-12, week-24, and week-52 ().
Component
Timepoint
Component respondents N
Absence of symptoms† N (%)
Severity reduction from baseline N (%)
Severity increase from baseline N (%)
Abdominal pain
Baseline
55
8 (15)
Week-12
22
9 (41)
11 (50)
5 (23)
Week-24
20
9 (45)
11 (55)
3 (15)
Week-52
12
7 (58)
9 (75)
1 (8)
Heartburn
Baseline
58
25 (45)
Week-12
28
14 (50)
11 (39)
5 (18)
Week-24
22
15 (68)
9 (41)
1 (5)
Week-52
14
8 (57)
6 (43)
3 (21)
Bloating
Baseline
59
1 (2)
Week-12
28
3 (11)
14 (50)
5 (18)
Week-24
22
5 (23)
14 (64)
5 (23)
Week-52
14
2 (14)
8 (57)
2 (14)
Nausea
Baseline
59
28 (47)
Week-12
28
17 (61)
8 (29)
3 (11)
Week-24
22
16 (73)
7 (32)
3 (14)
Week-52
14
9 (64)
5 (36)
3 (21)
Flatulence
Baseline
57
11 (19)
Week-12
28
2 (7)
11 (39)
12 (43)
Week-24
22
3 (14)
7 (32)
7 (32)
Week-52
14
1 (7)
5 (36)
7 (50)
Stool urgency
Baseline
57
15 (26)
Week-12
28
12 (43)
17 (61)
6 (21)
Week-24
21
9 (43)
11 (52)
3 (14)
Week-52
14
4 (29)
8 (57)
2 (14)
Incomplete stools
Baseline
56
6 (11)
Week-12
28
11 (39)
15 (54)
5 (18)
Week-24
22
8 (36)
13 (59)
3 (14)
Week-52
14
6 (43)
8 (57)
1 (7)
†A score of 0 which correlates to the absence of the associated symptom as described in Figure 2 legend. Stool frequency data is presented only in Figure 2.
